Cargando…

Robotic-Arm Assisted Total Knee Arthroplasty: Cost Savings Demonstrated at One Year

PURPOSE: Robotic-arm assisted total knee arthroplasty (RATKA) has the potential to enhance radiographic, clinical, and patient-reported outcomes. The purpose of this study was to compare resource utilization, episode-of-care (EOC) costs, readmissions, and complications of robotic-arm assisted total...

Descripción completa

Detalles Bibliográficos
Autores principales: Ong, Kevin L, Coppolecchia, Andréa, Chen, Zhongming, Watson, Heather N, Jacofsky, David, Mont, Michael A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075896/
https://www.ncbi.nlm.nih.gov/pubmed/35531481
http://dx.doi.org/10.2147/CEOR.S357112
_version_ 1784701788144795648
author Ong, Kevin L
Coppolecchia, Andréa
Chen, Zhongming
Watson, Heather N
Jacofsky, David
Mont, Michael A
author_facet Ong, Kevin L
Coppolecchia, Andréa
Chen, Zhongming
Watson, Heather N
Jacofsky, David
Mont, Michael A
author_sort Ong, Kevin L
collection PubMed
description PURPOSE: Robotic-arm assisted total knee arthroplasty (RATKA) has the potential to enhance radiographic, clinical, and patient-reported outcomes. The purpose of this study was to compare resource utilization, episode-of-care (EOC) costs, readmissions, and complications of robotic-arm assisted total knee arthroplasty (RATKA) and manual TKA (MTKA). METHODS: TKA procedures were identified from a private payer claims database. RATKA procedures required both a robotic arm-assisted procedure code and a 60-day pre-operative computed tomography scan. Propensity score matching (1:5 RATKA to MTKA) was performed, based on various patient characteristics and comorbidities. After matching, 4452 patients (742 RATKA and 3710 MTKA) were analyzed for 90-day and one-year EOC costs, index TKA costs, lengths of stay (LOS), discharge statuses, rehabilitation utilizations, as well as 90-day and one-year readmissions- and knee-related complications. RESULTS: RATKA patients had shorter LOS (mean 1.56 versus 1.91 days; p < 0.001), lower index costs by $1762 ($32,747 versus $34,509; p = 0.003), and higher discharges to home rates (51.8 versus 47.8%; p = 0.049) than MTKA patients. RATKA patients had less 90-day (68.5 versus 72.0%; p = 0.048) and one-year (70.8 versus 75.0%; p = 0.016) home health utilizations. The RATKA cohort had lower 90-day ($39,260 versus $41,458; p = 0.001) and one-year ($51,462 versus $54,171; p = 0.011) EOC costs. No significant differences in readmission and overall complication rates were observed (p > 0.05). CONCLUSION: RATKA was associated with lower index costs and EOC costs at both 90 days and one year. These patients had shorter LOS, were discharged home more frequently, and used less home health services. Cost savings were demonstrated for RATKA beyond the 90-day period with an increase in savings between 90-day and one-year time points. These data may be of importance to payers and providers interested in the longer-term value of RATKA.
format Online
Article
Text
id pubmed-9075896
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-90758962022-05-07 Robotic-Arm Assisted Total Knee Arthroplasty: Cost Savings Demonstrated at One Year Ong, Kevin L Coppolecchia, Andréa Chen, Zhongming Watson, Heather N Jacofsky, David Mont, Michael A Clinicoecon Outcomes Res Original Research PURPOSE: Robotic-arm assisted total knee arthroplasty (RATKA) has the potential to enhance radiographic, clinical, and patient-reported outcomes. The purpose of this study was to compare resource utilization, episode-of-care (EOC) costs, readmissions, and complications of robotic-arm assisted total knee arthroplasty (RATKA) and manual TKA (MTKA). METHODS: TKA procedures were identified from a private payer claims database. RATKA procedures required both a robotic arm-assisted procedure code and a 60-day pre-operative computed tomography scan. Propensity score matching (1:5 RATKA to MTKA) was performed, based on various patient characteristics and comorbidities. After matching, 4452 patients (742 RATKA and 3710 MTKA) were analyzed for 90-day and one-year EOC costs, index TKA costs, lengths of stay (LOS), discharge statuses, rehabilitation utilizations, as well as 90-day and one-year readmissions- and knee-related complications. RESULTS: RATKA patients had shorter LOS (mean 1.56 versus 1.91 days; p < 0.001), lower index costs by $1762 ($32,747 versus $34,509; p = 0.003), and higher discharges to home rates (51.8 versus 47.8%; p = 0.049) than MTKA patients. RATKA patients had less 90-day (68.5 versus 72.0%; p = 0.048) and one-year (70.8 versus 75.0%; p = 0.016) home health utilizations. The RATKA cohort had lower 90-day ($39,260 versus $41,458; p = 0.001) and one-year ($51,462 versus $54,171; p = 0.011) EOC costs. No significant differences in readmission and overall complication rates were observed (p > 0.05). CONCLUSION: RATKA was associated with lower index costs and EOC costs at both 90 days and one year. These patients had shorter LOS, were discharged home more frequently, and used less home health services. Cost savings were demonstrated for RATKA beyond the 90-day period with an increase in savings between 90-day and one-year time points. These data may be of importance to payers and providers interested in the longer-term value of RATKA. Dove 2022-05-02 /pmc/articles/PMC9075896/ /pubmed/35531481 http://dx.doi.org/10.2147/CEOR.S357112 Text en © 2022 Ong et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Ong, Kevin L
Coppolecchia, Andréa
Chen, Zhongming
Watson, Heather N
Jacofsky, David
Mont, Michael A
Robotic-Arm Assisted Total Knee Arthroplasty: Cost Savings Demonstrated at One Year
title Robotic-Arm Assisted Total Knee Arthroplasty: Cost Savings Demonstrated at One Year
title_full Robotic-Arm Assisted Total Knee Arthroplasty: Cost Savings Demonstrated at One Year
title_fullStr Robotic-Arm Assisted Total Knee Arthroplasty: Cost Savings Demonstrated at One Year
title_full_unstemmed Robotic-Arm Assisted Total Knee Arthroplasty: Cost Savings Demonstrated at One Year
title_short Robotic-Arm Assisted Total Knee Arthroplasty: Cost Savings Demonstrated at One Year
title_sort robotic-arm assisted total knee arthroplasty: cost savings demonstrated at one year
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9075896/
https://www.ncbi.nlm.nih.gov/pubmed/35531481
http://dx.doi.org/10.2147/CEOR.S357112
work_keys_str_mv AT ongkevinl roboticarmassistedtotalkneearthroplastycostsavingsdemonstratedatoneyear
AT coppolecchiaandrea roboticarmassistedtotalkneearthroplastycostsavingsdemonstratedatoneyear
AT chenzhongming roboticarmassistedtotalkneearthroplastycostsavingsdemonstratedatoneyear
AT watsonheathern roboticarmassistedtotalkneearthroplastycostsavingsdemonstratedatoneyear
AT jacofskydavid roboticarmassistedtotalkneearthroplastycostsavingsdemonstratedatoneyear
AT montmichaela roboticarmassistedtotalkneearthroplastycostsavingsdemonstratedatoneyear